Our scientifically proven platform, InSight, can test multiple small molecule drugs simultaneously for their neuroprotective, antioxidative and anti-inflammatory as well as neurotoxic effects in functionally viable human retina tissue.

One of the biggest bottle necks in translating in vitro findings to successful therapies is the delivery to the target cells in vivo. We offer a novel platform for evaluating efficient delivery and transfection of the target tissues-cells in the human eye.

We consult, design and build research tools for ex vivo and ex-situ functional assessment of the retina.